News
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
The
How to Boost Your Portfolio with Top Consumer Discretionary Stocks Set to Beat Earnings
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Despite Fast-paced Momentum, ZIM (ZIM) Is Still a Bargain Stock
Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks
Why Investors Need to Take Advantage of These 2 Utilities Stocks Now
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
The
SSAB (SSAAY) Is Attractively Priced Despite Fast-paced Momentum
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that
Legato Merger (ASTL) Shows Fast-paced Momentum But Is Still a Bargain Stock
Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that
Columbia Financial (CLBK) Matches Q4 Earnings Estimates
Columbia Financial (CLBK) came out with quarterly earnings of $0.15 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.11 per share a year ago. These figures are
These 2 Oils and Energy Stocks Could Beat Earnings: Why They Should Be on Your Radar
Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure
Sonos Set to Report Q1 Earnings: Here's What You Should Know
Sonos, Inc. SONO is scheduled to report first-quarter fiscal 2026 results on Feb. 3, after market close.
For the quarter, SONO anticipates revenues between $510 million and $560 million, implying a
National Fuel Gas Q1 Earnings Beat Estimates, Gas Production Up
National Fuel Gas Company NFG reported first-quarter fiscal 2026 adjusted operating earnings of $2.06 per share, which beat the Zacks Consensus Estimate of $1.91 by 7.85%. The bottom line also
4 Software Stocks Set to Pull Off a Beat This Earnings Season
Software stocks continue to ride on a strong demand cycle, supported by steady digital transformation and the fast adoption of artificial intelligence (AI). AI, generative AI and now Agentic AI are
PTC to Report Q1 Earnings: Here's What Investors Should Expect
PTC Inc. PTC is scheduled to report first-quarter fiscal 2026 results on Feb. 4, after market close.For the quarter, PTC anticipates revenues between $600 million and $660 million. Non-GAAP EPS is
Beat the Market the Zacks Way: Five Below, Novo Nordisk, Ekso in Focus
Last Friday, the three most widely followed benchmark indexes closed a mixed week. The Dow Jones Industrial Average and the Nasdaq Composite receded 0.4% and 0.2%, respectively, while the S&P 500
Qualys Gears Up to Report Q4 Earnings: What to Expect From the Stock?
Qualys, Inc. QLYS is scheduled to report fourth-quarter 2025 earnings on Feb. 5, after market close.
For the fourth quarter, QLYS anticipates revenues between $172 million and $174 million. The
Murphy Q4 Earnings & Sales Beat Estimates, Reserve Replacement Is 103%
Murphy Oil Corporation MUR delivered fourth-quarter 2025 adjusted net earnings of 14 cents per share, outperforming the Zacks Consensus Estimate of a loss of 7 cents by 300%. However, the bottom
4 Defensive Stocks to Buy as Consumer Confidence Dips to12-Year Low
Americans are fast losing confidence as the nation’s economic health continues to raise concerns. A tightening labor market, coupled with high prices, has already led to a decline in consumer
Here's How Much a $1000 Investment in Onto Innovation Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
Here's How Much a $1000 Investment in Petrobras Made 10 Years Ago Would Be Worth Today
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and
If You Invested $1000 in Teck Resources Ltd a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and
Here's How Much You'd Have If You Invested $1000 in Interactive Brokers Group, Inc. a Decade Ago
How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across
If You Invested $1000 in Monster Beverage a Decade Ago, This is How Much It'd Be Worth Now
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors
Twist Bioscience (TWST) Reports Q1 Loss, Misses Revenue Estimates
Twist Bioscience (TWST) came out with a quarterly loss of $0.5 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to a loss of $0.53 per share a year ago. These figures
Should You Buy Celestica as a Global Leader in AI-Powered EMS Space?
Celestica Inc. CLS — one of the largest AI-powered EMS (electronics manufacturing services) companies in the world — reported excellent fourth-quarter 2025 earnings results. Adjusted earnings per


